MAXIPIRIN C 400mg / 240mg effervescent tablets medication leaflet

N02BA51 acetylsalicylic acid + ascorbic acid • Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Acetylsalicylic acid + ascorbic acid is a combination medication primarily used to relieve symptoms of colds and flu, such as fever, headaches, muscle pain, and inflammation. Acetylsalicylic acid (aspirin) has analgesic, antipyretic, and anti-inflammatory properties, while ascorbic acid (vitamin C) supports the immune system.

This combination is usually available in the form of effervescent tablets, which are dissolved in water before administration. Ascorbic acid helps compensate for vitamin C losses in the body during viral infections.

Common side effects may include gastric irritation, nausea, or heartburn, and long-term or high-dose use may increase the risk of gastrointestinal bleeding. It is contraindicated in patients with active gastric ulcers, bleeding disorders, or salicylate allergies.

Acetylsalicylic acid + ascorbic acid is not recommended for children under 16 years old due to the risk of Reye's syndrome, a rare but serious condition. Consult a doctor before use, especially if you are taking other anticoagulant or anti-inflammatory medications.

General data about MAXIPIRIN C 400mg / 240mg

Substance: acetylsalicylic acid + ascorbic acid

Date of last drug list: 01-05-2025

Commercial code: W71060002

Concentration: 400mg / 240mg

Pharmaceutical form: effervescent tablets

Quantity: 2

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: E-PHARMA TRENTO S.P.A. - ITALIA

Holder: DR. MAX PHARMA S.R.O. - REPUBLICA CEHA

Number: 15948/2025/02

Shelf life: 6 months-after packing for marketing;after the first opening of the tube-90 days

Concentrations available for acetylsalicylic acid + ascorbic acid

330mg/200mg, 400mg/240mg, 800mg/480mg

Other substances similar to acetylsalicylic acid + ascorbic acid